Clinical Trials in Ohio

Showing 10461-10480 of 20,938 trials

A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD

NCT03573817

The primary objective of the study was to characterize the safety and tolerability of once-daily revefenacin inhalation solution when dosed sequentially with twice-daily formoterol inhalation solution (PERFOROMIST®) compared to PERFOROMIST®, in a population of participants with moderate-to-very severe Chronic Obstructive Pulmonary Disease (COPD) over 21 days.

Chronic Obstructive Pulmonary Disease (COPD)

Mylan Inc.122 participantsStarted May 2018

Miami, Florida, United States • Orlando, Florida, United States • Sarasota, Florida, United States +9 more locations

COMPLETEDPhase 332 miles

Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years

NCT02725593

A trial of patients aged 10-24 years with type 2 diabetes mellitus to evaluate the comparative efficacy and safety between dapagliflozin and Placebo.

Type 2 Diabetes

AstraZeneca72 participantsStarted Jun 2016

New Haven, Connecticut, United States • Washington D.C., District of Columbia, United States • Gainesville, Florida, United States +39 more locations

A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD

Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years

Find Trials by Condition in Ohio

Herniorrhaphy Study for Opioid Elimination

Ultralow Versus Standard Pneumoperitoneum Pressure

Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell Lymphoma

A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis

PF-06651600 for the Treatment of Alopecia Areata

Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis

Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2

Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma

A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)

Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer

A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oratecan in Subjects With Advanced Malignancies

Expanded Access Remdesivir (RDV; GS-5734™)

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple Myeloma

Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus

A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered in Combination With Hu5F9-G4 to Patients With Relapsed and/or Refractory Acute Myeloid Leukemia

Comparison of Visual Acuity Performed in Office Versus In Residence